Likewise, an elevated level of GLS2 observed in the nuclei of PMA-treated neuroblastoma SH-SY5Y cells was accompanied by significantly increased amounts of p53, p21, and cell cycle arrest at the G2/M stage. This evidence concerns the gene GLS2 and neuroblastoma.